Similarly, the observed cardioprotective effect of AMPK against pressure-overload-induced ventricular hypertrophy and dysfunction [16] can also be attributed in part to the AMPK-induced β-adrenergic pathway down-regulation. Here, PRKAA1 is linked to cardiac hypertrophy.